Pabociclib Impurity B
An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer.
| Supplier | BOC Sciences |
|---|---|
| Product # | B1476-478509 |
| Pricing | 100 mg/unit USD $646 |
| Cas | 1651214-74-2 |
| Molecular Weight | 547.66 |
| Molecular Formula | C29H37N7O4 |
| Canonical SMILES | CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCN(CC4)C(=O)OC(C)(C)C)C5CCCC5)C(=O)C |